BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 22306906)

  • 1. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
    Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
    J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4.
    Holt D; Ma X; Kundu N; Fulton A
    Cancer Immunol Immunother; 2011 Nov; 60(11):1577-86. PubMed ID: 21681369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2.
    Ma X; Kundu N; Collin PD; Goloubeva O; Fulton AM
    Breast Cancer Res Treat; 2012 Apr; 132(3):1001-8. PubMed ID: 21761157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
    Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation.
    Park A; Lee Y; Kim MS; Kang YJ; Park YJ; Jung H; Kim TD; Lee HG; Choi I; Yoon SR
    Front Immunol; 2018; 9():1859. PubMed ID: 30140269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
    Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
    Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
    Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous prostaglandin E
    Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
    J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion.
    Spinella F; Rosanò L; Di Castro V; Natali PG; Bagnato A
    J Biol Chem; 2004 Nov; 279(45):46700-5. PubMed ID: 15347673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evidence that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils.
    Lavoie JC; Simard M; Kalkan H; Rakotoarivelo V; Huot S; Di Marzo V; Côté A; Pouliot M; Flamand N
    J Leukoc Biol; 2024 May; 115(6):1183-1189. PubMed ID: 38345417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
    Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
    Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 receptors of the EP2 and EP4 subtypes downregulate tumor necrosis factor alpha-induced intercellular adhesion molecule-1 expression in human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Ishikawa I
    J Periodontal Res; 1999 Nov; 34(8):478-85. PubMed ID: 10697805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGE
    Rastogi S; Willmes DM; Nassiri M; Babina M; Worm M
    J Allergy Clin Immunol; 2020 Dec; 146(6):1387-1396.e13. PubMed ID: 32407837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E prostanoid 2 (EP2)/EP4-mediated suppression of antigen-specific human T-cell responses by prostaglandin E2.
    Okano M; Sugata Y; Fujiwara T; Matsumoto R; Nishibori M; Shimizu K; Maeda M; Kimura Y; Kariya S; Hattori H; Yokoyama M; Kino K; Nishizaki K
    Immunology; 2006 Jul; 118(3):343-52. PubMed ID: 16827895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic regulation by prostaglandin E
    Robb CT; Zhou Y; Felton JM; Zhang B; Goepp M; Jheeta P; Smyth DJ; Duffin R; Vermeren S; Breyer RM; Narumiya S; McSorley HJ; Maizels RM; Schwarze JKJ; Rossi AG; Yao C
    Allergy; 2023 Mar; 78(3):714-730. PubMed ID: 36181709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell-intrinsic prostaglandin E
    Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
    J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.